-
-
-
-
-
-
-
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q3 EPS by 57c
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics Announces First Quarter 2025 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product Revenue
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q2 EPS by 57c, provides guidance
-
-
-
-
-
-
-
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
-
1,216,199 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

